Nissay Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Nissay Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.39M	Buy	142,638 +4,252	+3%	+$71.3K	0.01%	469
2025 Q1	$2.13M	Sell	138,386 -663	-0.5%	-$10.2K	0.01%	498
2024 Q4	$3.17M	Buy	139,049 +1,575	+1%	+$35.9K	0.02%	411
2024 Q3	$2.48M	Buy	137,474 +3,597	+3%	+$64.8K	0.02%	477
2024 Q2	$2.18M	Buy	133,877 +3,066	+2%	+$49.8K	0.01%	477
2024 Q1	$1.85M	Buy	130,811 +1,976	+2%	+$27.9K	0.01%	528
2023 Q4	$1.35M	Buy	128,835 +5,098	+4%	+$53.2K	0.01%	566
2023 Q3	$1.26M	Buy	123,737 +4,658	+4%	+$47.5K	0.01%	559
2023 Q2	$897K	Sell	119,079 -1,770	-1%	-$13.3K	0.01%	636
2023 Q1	$1.07M	Sell	120,849 -4,589	-4%	-$40.6K	0.01%	590
2022 Q4	$1.14M	Sell	125,438 -6,053	-5%	-$55.2K	0.01%	564
2022 Q3	$1.06M	Buy	131,491 +5,103	+4%	+$41.2K	0.01%	575
2022 Q2	$950K	Sell	126,388 -1,194	-0.9%	-$8.98K	0.01%	588
2022 Q1	$1.2M	Buy	127,582 +2,233	+2%	+$21K	0.01%	576
2021 Q4	$1M	Buy	125,349 +5,097	+4%	+$40.8K	0.01%	641
2021 Q3	$1.17M	Buy	120,252 +4,436	+4%	+$43.2K	0.01%	592
2021 Q2	$1.15M	Sell	115,816 -6,278	-5%	-$62.2K	0.01%	602
2021 Q1	$1.41M	Buy	122,094 +1,709	+1%	+$19.7K	0.01%	525
2020 Q4	$1.16M	Buy	120,385 +3,292	+3%	+$31.8K	0.02%	548
2020 Q3	$1.06M	Sell	117,093 -30,947	-21%	-$279K	0.02%	523
2020 Q2	$1.83M	Sell	148,040 -20,266	-12%	-$250K	0.04%	386
2020 Q1	$1.51M	Buy	168,306 +68,700	+69%	+$617K	0.04%	370
2019 Q4	$976K	Buy	99,606 +1,439	+1%	+$14.1K	0.02%	532
2019 Q3	$675K	Sell	98,167 -65,237	-40%	-$449K	0.02%	595
2019 Q2	$1.51M	Buy	163,404 +28,462	+21%	+$263K	0.04%	404
2019 Q1	$2.12M	Sell	134,942 -8,117	-6%	-$127K	0.06%	350
2018 Q4	$2.21M	Buy	143,059 +3,680	+3%	+$56.7K	0.07%	325
2018 Q3	$3M	Buy	139,379 +17,497	+14%	+$377K	0.08%	292
2018 Q2	$2.96M	Buy	121,882 +812	+0.7%	+$19.7K	0.09%	286
2018 Q1	$2.07M	Buy	121,070 +44,026	+57%	+$752K	0.06%	326
2017 Q4	$1.46M	Buy	+77,044	New	+$1.46M	0.04%	348